Adage Capital Partners Gp, L.L.C. Incyte Corp Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $2.35 Million - $2.76 Million	41,499 New	41,499 $2.36 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $32.6 Million - $40.8 Million	-493,000 Reduced 68.37%	228,109 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $57.7 Million - $72.5 Million	-871,700 Reduced 54.73%	721,109 $54.8 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $72.5 Million - $87.5 Million	1,097,700 Added 221.71%	1,592,809 $127 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $16.9 Million - $19.8 Million	266,562 Added 116.63%	495,109 $36.3 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $13.7 Million - $16.8 Million	-199,825 Reduced 46.65%	228,547 $15.7 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $24.2 Million - $26.6 Million	-303,500 Reduced 41.47%	428,372 $36 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $50.9 Million - $67.3 Million	670,070 Added 1084.22%	731,872 $59.5 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $2.63 Million - $3.19 Million	-32,600 Reduced 34.53%	61,802 $5.38 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $5.33 Million - $6.87 Million	-62,600 Reduced 39.87%	94,402 $8.47 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $1.06 Million - $1.56 Million	14,300 Added 10.02%	157,002 $16.3 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.48 Million - $2.01 Million	-23,350 Reduced 14.06%	142,702 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $2.93 Million - $3.84 Million	40,100 Added 31.84%	166,052 $14.5 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $145,640 - $173,040	-2,000 Reduced 1.56%	125,952 $9.35 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $466,484 - $562,801	-6,345 Reduced 4.72%	127,952 $10.9 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $711,872 - $987,504	11,200 Added 9.1%	134,297 $11.6 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $2.36 Million - $2.82 Million	40,280 Added 48.64%	123,097 $7.83 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.38 Million - $1.66 Million	-22,360 Reduced 21.26%	82,817 $5.72 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $7.82 Million - $10.8 Million	-128,530 Reduced 55.0%	105,177 $7.05 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $3.91 Million - $4.76 Million	47,100 Added 25.24%	233,707 $19.5 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $1.89 Million - $2.36 Million	20,200 Added 12.14%	186,607 $17.7 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $18.2 Million - $23 Million	166,407	166,407 $19.4 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account